Related Experiment Video
Updated: Aug 14, 2026

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
Published on: February 17, 2016
Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive multifocal
H T Agostini1, C F Ryschkewitsch, R W Baumhefner
1Neurotoxicology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, MD 20892, USA.
Abstract:
Two features of the biology of JC virus make it a particularly suitable candidate for an agent in MS-like disease: its neurotropic capability targeting glial cells as evidenced in progressive multifocal leukoencephalopathy lesions, and its capacity for latency and persistence as illustrated by its behaviour in the kidney. JC virus is chronically or intermittently excreted in the urine by some 40% of the population. The existence of JC virus in multiple coding-region genotypes provides a unique approach to the study of JC virus-induced neurological disease. We have previously shown that a genotype originating in Asia but also present in Europe and the US, called Type 2B, is more frequently found in PML brain than expected based on its prevalence in urine samples from a control population. In contrast, we find that the excretion of JCV in MS patients is similar in both genotype and frequency to that of control individuals, and appears to be regulated by factors unrelated to those that control CNS disease activity.
Insights
JC virus, a neurotropic pathogen, is investigated for its role in MS-like disease. While certain genotypes are linked to PML, JC virus excretion in MS patients mirrors that of controls, suggesting other factors influence CNS disease.
Area of Science:
- Virology
- Neuroscience
- Immunology
Background:
- JC virus (JCV) exhibits neurotropism, targeting glial cells, and can establish latency, making it a candidate for MS-like diseases.
- JCV is shed in urine by approximately 40% of the population, with multiple coding-region genotypes identified.
- Previous research indicated a higher prevalence of the JCV Type 2B genotype in progressive multifocal leukoencephalopathy (PML) brain tissue compared to urine samples from controls.
Purpose of the Study:
- To investigate the role of JC virus genotypes in the pathogenesis of Multiple Sclerosis (MS).
- To compare the prevalence and genotypes of JC virus shed in urine by MS patients versus control individuals.
- To explore the relationship between JC virus shedding, specific genotypes, and central nervous system (CNS) disease activity in MS.
Main Methods:
- Analysis of JC virus genotypes in urine samples from MS patients and a control population.
- Comparison of the frequency of JC virus excretion between MS patients and controls.
- Correlation analysis between JC virus genotype prevalence, shedding frequency, and MS disease activity.
Main Results:
- The excretion frequency and genotype distribution of JC virus in MS patients were found to be similar to those in control individuals.
- This contrasts with previous findings where a specific genotype (Type 2B) was overrepresented in PML brain lesions.
- The findings suggest that JC virus shedding in MS is regulated by factors independent of those controlling CNS disease activity.
Conclusions:
- JC virus shedding patterns in MS patients do not differ significantly from the general population.
- The factors controlling JC virus latency and shedding in the kidneys appear distinct from those influencing its potential role in MS pathogenesis.
- Further research is needed to elucidate the precise mechanisms, if any, by which JC virus may contribute to MS-like neurological conditions.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Arboviral Encephalitis
Cytomegalovirus Disease
Cryptococcal Meningitis
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction

